P&T COMMUNITY
 
MediMedia Managed Markets
Our
Other
Journal
Managed Care magazine
Login / Register
Join Us  Facebook  Twitter  Linked In
About P&T Journal
Contacts:
Editorial: Sonja Sherritze, Editor
Advertising: Maureen Dwyer Liberti,
    Vice President, Group Publisher

Production: Mary Ellen Curry,
    Director of Production Services

Circulation: Jackie Ott, Circulation Manager


Statement of Purpose
Guidelines for Authors
Masthead
Editorial Board
Reprints


Recent Issues

November 2009

Features

Health Care and Law

Mandatory Vaccination of Health Care Workers

Whose Rights Should Come First?

Despite government recommendations that health care professionals be vaccinated against the H1N1 influenza in order to protect patients, a significant number of workers intend to refuse the vaccine. Dr. Field reviews the legal status of the mandates for vaccination as well as viewpoints for and against compliance.
Robert I. Field, JD, MPH, PhD

Humor

What’s in a Name?

These days, it seems that just about everyone is emotionally attached to a brand-name electronic device, a designer T-shirt, or a gym bag with a pharma logo. The author, a reluctant consumer, ponders the power of brands.
Nancy Greengold, MD, MBA

Q & A

An Interview Series with Members of the ASHP Expert Panel on Formulary Management

Part 1: Linda S. Tyler, PharmD

In the first of a three-part series, topics such as drug approvals and shortages, therapeutic interchanges, and pharmacoeconomic assessments are discussed.
C. Lee Ventola, MS

Meeting Highlights

American Society for Bone and Mineral Research

Agents for postmenopausal osteoporosis are reviewed.
Walter Alexander

FDA Public Health Alert

Heparin Revisions

A Call for Heightened Vigilance and Monitoring

As a result of the contamination of unfractionated heparin, changes in the product’s potency have been made to ensure its purity and safety.
Walter Alexander

Pharmaceutical Approval Update

Topics include pralatrexate (Folotyn) for lymphoma; telavancin (Vibativ) for skin infections; and bepotastine besilate (Bepreve), an eyedrop for conjunctivitis.
Marvin M. Goldenberg, PhD, RPh, MS

Departments

Editorial

Take Back Our Profession

David B. Nash, MD, MBA, recounts his talk to physicians-in-training on the topics of professionalism and responsibility.
David B. Nash, MD, MBA

Medication Errors

Patient Safety Brochures

What Do They Really Say about Safety?

Matthew Grissinger, RPh, FASCP, emphasizes the importance of providing appropriate safety tips in brochures for patients.
Matthew Grissinger, RPh, FASCP

Prescription: Washington

Hospital Pharmacists Worry about Definition of ‘Meaningful Use’

Will They Be Eligible for Federal Electronic Health Record Grants?

Stephen Barlas discusses the challenges faced by hospitals in meeting the criteria for “meaningful use” when installing health information technology.
Stephen Barlas

New Drugs/Drug News/New Medical Devices

From Berinert to Votrient, P&T presents the latest studies and information about FDA approvals, recalls, and industry updates.

Drug Forecast

Iloperidone (Fanapt): An FDA-Approved Treatment Option for Schizophrenia

Authors Montes and Rey review iloperidone (Fanapt) for the treatment of schizophrenia.
Amy Barbara Montes, PharmD, and Jose A. Rey, PharmD, BCPP